Enliven Therapeutics Inc

ELVN06 Dec 2024
Healthcare
$23.67
-0.02 (-1.94%)
Lowest Today
$23.12
Highest Today
$23.67
Today’s Open
$23.67
Prev. Close
$23.71
52 Week High
$30.03
52 Week Low
$9.8
To Invest in Enliven Therapeutics Inc

Enliven Therapeutics Inc

Healthcare
ELVN06 Dec 2024
-0.02 (-1.94%)
1M
3M
6M
1Y
5Y
Low
$23.12
Day’s Range
High
$23.67
23.12
52 Week Low
$9.8
52-Week Range
52 Week High
$30.03
9.8
1 Day
-
1 Week
-5.16%
1 month return
-21.75%
3 month return
+6.83%
6 month return
+14.67%
1 Year return
+110.27%
3 Years return
+102.89%
5 Years return
-
10 Years return
-

Market Status

Fundamentals
Market Cap
1158.45 mln
PB Ratio
4.02
PE Ratio
0
Enterprise Value
866.7 mln
Total Assets
271.87 mln
Volume

Company Financials

Fund house & investment objective

Company Information
Enliven Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of small molecule inhibitors to help patients with cancer. The company's lead product candidates comprise ELVN-001, which is being evaluated in a Phase 1 clinical trial in adults with chronic myeloid leukemia; and ELVN-002, a Phase 1 clinical trial in adults with solid tumors with HER2 alterations. The company is headquartered in Boulder, Colorado.
Organisation
Enliven Therapeutics Inc
Employees
46
Industry
Biotechnology
CEO
Mr. Samuel S. Kintz M.B.A.
Trading and brokerage services provided by
Technology Services provided by Motilal Oswal Financial Services:

Take your next step

Click here to see your activities